Impact of Sex on Office White Coat Effect Tail: Investigating Two Italian Residential Cohorts.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
21 11 2019
21 11 2019
Historique:
received:
13
06
2019
accepted:
28
10
2019
entrez:
23
11
2019
pubmed:
23
11
2019
medline:
6
11
2020
Statut:
epublish
Résumé
To assess the impact of sex on office white-coat effect tail (OWCET), the waning of systolic blood pressure (SBP) after its waxing during office visit, on the incidence of long-term major fatal and non-fatal events in two Italian residential cohorts [from the Gubbio Study and the Italian Rural Areas of the Seven Countries Study (IRA)]. There were 3565 persons (92 with missing data, 44% men, 54 ± 11 years) included in the Gubbio and 1712 men (49 ± 5 years) in the IRA studies. OWCET was defined as a decrease of ≥10 mmHg in SBP between successive measurements with slight measurement differences between the two cohorts. Cardiovascular (CVD), coronary heart disease (CHD) and stroke (STR) incidences were considered. Over an approximately 20-year follow-up, women with OWCET had an increased risk of CVD [HR: 1.591 (95%CI: 1.204-2.103)], CHD [HR: 1.614 (95%CI: 1.037-2.512)] and STR [HR: 1.696 (95%CI: 1.123-2.563)] events independently of age, serum and HDL cholesterol, cigarettes, BMI and SBP in the Gubbio study. However, there was no increased risk of CVD, CHD or STR in men with OWCET neither in the Gubbio 20-year follow-up nor in the IRA 50-year follow-up. These results were not modified significantly by the correction of the regression dilutions bias between the first and the subsequent SBP measurements. Thus, in primary care, OWCET should be actively evaluated in women as it can improve stratification of long-term CVD, CHD and STR risks.
Identifiants
pubmed: 31754227
doi: 10.1038/s41598-019-53109-1
pii: 10.1038/s41598-019-53109-1
pmc: PMC6872870
doi:
Substances chimiques
Cholesterol, HDL
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
17237Références
Eur J Prev Cardiol. 2016 Mar;23(4):340-8
pubmed: 25986497
J Hypertens. 2016 Apr;34(4):613-22
pubmed: 26848994
Lancet. 1990 Mar 31;335(8692):765-74
pubmed: 1969518
Clin Chem. 1956 Jun;2(3):145-59
pubmed: 13317101
Circulation. 1970 Apr;41(4 Suppl):I63-75
pubmed: 5445350
J Am Coll Cardiol. 2016 Nov 8;68(19):2033-2043
pubmed: 27810041
Am J Hypertens. 2008 Feb;21(2):153-8
pubmed: 18174883
Ann Fam Med. 2010 Jan-Feb;8(1):25-32
pubmed: 20065275
Eur J Intern Med. 2013 Jan;24(1):67-74
pubmed: 22954458
Arq Bras Cardiol. 2003 Feb;80(2):117-26
pubmed: 12640506
J Hypertens. 2018 Sep;36(9):1825-1832
pubmed: 29846329
Int J Epidemiol. 2014 Jun;43(3):713-20
pubmed: 23543599
J Hypertens. 2010 May;28(5):910-7
pubmed: 20139769
Int J Cardiol. 2014 May 1;173(2):300-4
pubmed: 24673970
Vasc Health Risk Manag. 2010 May 06;6:297-305
pubmed: 20479952
Blood Press Monit. 1999 Dec;4(6):333-41
pubmed: 10602537
J Hypertens. 2009 Feb;27(2):266-74
pubmed: 19155784
J Am Geriatr Soc. 2000 Jul;48(7):741-5
pubmed: 10894311
J Hypertens. 2015 Apr;33(4):736-44; discussion 744
pubmed: 25915878
Aging Clin Exp Res. 2018 Aug;30(8):901-911
pubmed: 29256065
Eur J Prev Cardiol. 2016 Nov;23(17):1831-1838
pubmed: 27330021
Int J Cardiol. 2014 Feb 15;171(3):361-7
pubmed: 24388539
Hypertension. 1997 Jun;29(6):1218-24
pubmed: 9180621
Prev Med. 2014 Oct;67:242-7
pubmed: 25117521
Lancet. 1983 Sep 24;2(8352):695-8
pubmed: 6136837
Blood Press Monit. 2011 Feb;16(1):1-6
pubmed: 21178767